In a regulatory filing, Inari Medical disclosed that its director William Hoffman sold 25K shares of common stock on August 15th in a total transaction size of $1.73M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NARI:
- Inari Medical price target lowered to $90 from $92 at Piper Sandler
- Inari Medical price target lowered to $100 from $105 at Wells Fargo
- Inari Medical raises FY23 revenue view to $482M-$492M from $478M-$488M
- Inari Medical reports Q2 EPS 4c, consensus (19c)
- Inari Medical Reports Second Quarter 2023 Financial Results